Pancreatic Cancer Market Developments Signal Major Shifts in Supply Chain and Technology Adoption
Market Overview According to the research report, the global pancreatic cancer market was valued at USD 2.32 million in 2021 and is expected to reach USD 7.04 billion by 2030, to grow at a CAGR of 13.8% during the forecast period. The global pancreatic cancer market is segmented based on treatment type, diagnostic methods, end-users, and geography. Traditional treatment modalities like surgery, radiation therapy, and chemotherapy remain the mainstay for many patients. However, there has been a notable shift toward precision medicine, with biomarker-driven therapies gaining traction. Diagnostic techniques such as MRI, CT scans, endoscopic ultrasound, and liquid biopsy are playing a pivotal role in early detection and staging of the disease. Despite challenges related to late diagnosis and high treatment costs, the market is expected to expand significantly over the next decade. The integration of artificial intelligence in diagnostics, personalized treatment planning, ...